Literature DB >> 5822574

Measurement of thrombopoiesis in rabbits using 75selenomethionine.

B L Evatt, J Levin.   

Abstract

Incorporation of (75)selenomethionine ((75)SeM) has been used to study platelet production in rabbits. Radioactivity of platelets was low after the intravenous administration of (75)SeM and rose to a maximum approximately 3 days after administration. Platelet radioactivity was independent of concurrent plasma levels. The life span of rabbit platelets, as estimated with this technique, was 4-5 days. In vivo reutilization of (75)SeM previously incorporated into plasma proteins was not detected. In vitro incorporation of (75)SeM by platelets in platelet-rich plasma was not demonstrated. Acute hemorrhage 24 hr before administration of (75)SeM increased the incorporation of (75)SeM into platelets. Transfusion-induced thrombocytosis reduced the incorporation of (75)SeM to approximately 30% of that observed in control animals. Suppression of bone marrow function with nitrogen mustard resulted in decreased numbers of platelets in the circulation, and a decrease in incorporation of (75)SeM. Delayed appearance of (75)SeM was observed in circulating platelets during recovery from marrow suppression. Injection of 75-225 ml of plasma from thrombocytopenic donors into normal rabbits increased incorporation of (75)SeM into platelets while normal plasma did not have this effect. The rate of appearance of (75)SeM in circulating platelets appears to provide a sensitive and specific method for the study of production of platelets by megakaryocytes. The data suggest more rapid entry of platelets into the circulation, and a sustained increase in incorporation of (75)SeM into platelet protein after stimulation of platelet production. The results are consistent with the concept of a humoral agent (thrombopoietin) that acts on megakaryocytes to regulate platelet production.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5822574      PMCID: PMC535733          DOI: 10.1172/JCI106127

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  TWO MECHANISMS OF SULFATE-S35 UPTAKE BY BLOOD PLATELETS OF RATS.

Authors:  T T ODELL; T P MCDONALD
Journal:  Am J Physiol       Date:  1964-03

2.  PLATELET SIZE IN RELATION TO PLATELET AGE.

Authors:  T P MCDONALD; T T ODELL; D G GOSSLEE
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

3.  TRANSMUCOSAL MOVEMENT OF SELENIUM.

Authors:  K P MCCONNELL; G J CHO
Journal:  Am J Physiol       Date:  1965-06

4.  MEGAKARYOCYTOPOIESIS IN THE RAT.

Authors:  S EBBE; F STOHLMAN
Journal:  Blood       Date:  1965-07       Impact factor: 22.113

5.  Platelet life span as measured by transfusion of isotopically labeled platelets into rats.

Authors:  T T ODELL; F G TAUSCHE; J FURTH
Journal:  Acta Haematol       Date:  1955-01       Impact factor: 2.195

6.  Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency.

Authors:  I SCHULMAN; M PIERCE; A LUKENS; Z CURRIMBHOY
Journal:  Blood       Date:  1960-07       Impact factor: 22.113

7.  Humoral regulation of red cell production.

Authors:  A ERSLEV
Journal:  Blood       Date:  1953-04       Impact factor: 22.113

8.  Response of rat megakaryocytes and platelets to bleeding.

Authors:  T T ODELL; T P McDONALD; M ASANO
Journal:  Acta Haematol       Date:  1962       Impact factor: 2.195

Review 9.  Thrombopoiesis.

Authors:  C F Abildgaard; J V Simone
Journal:  Semin Hematol       Date:  1967-10       Impact factor: 3.851

10.  Depression of the megakaryocyte-platelet system in rats by transfusion of platelets.

Authors:  T T Odell; C W Jackson; R S Reiter
Journal:  Acta Haematol       Date:  1967       Impact factor: 2.195

View more
  11 in total

1.  Platelet alpha-granule fibrinogen, albumin, and immunoglobulin G are not synthesized by rat and mouse megakaryocytes.

Authors:  P Handagama; D A Rappolee; Z Werb; J Levin; D F Bainton
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  Slowed decay of mRNAs enhances platelet specific translation.

Authors:  Eric W Mills; Rachel Green; Nicholas T Ingolia
Journal:  Blood       Date:  2017-02-17       Impact factor: 22.113

3.  Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.

Authors:  R J Hill; M K Warren; J Levin
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.

Authors:  T Ishibashi; H Kimura; T Uchida; S Kariyone; P Friese; S A Burstein
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin.

Authors:  R I Roth; F C Levin; J Levin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

Review 6.  Significance of polyploidy in megakaryocytes and other cells in health and tumor disease.

Authors:  M Winkelmann; P Pfitzer; W Schneider
Journal:  Klin Wochenschr       Date:  1987-12-01

7.  Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.

Authors:  D C Foster; C A Sprecher; F J Grant; J M Kramer; J L Kuijper; R D Holly; T E Whitmore; M D Heipel; L A Bell; A F Ching
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Detection of thrombopoietic activity in plasma by stimulation of suppressed thrombopoiesis.

Authors:  D P Shreiner; J Levin
Journal:  J Clin Invest       Date:  1970-09       Impact factor: 14.808

9.  The kinetics of hematopoiesis in the light horse. I. The lifespan of peripheral blood cells in the normal horse.

Authors:  E I Carter; V E Valli; B J McSherry; F J Milne; G A Robinson; J H Lumsden
Journal:  Can J Comp Med       Date:  1974-07

10.  Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.

Authors:  R Nachman; R Levine; E A Jaffe
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.